Efficacy of flecainide in patients with supraventricular arrhythmias and respiratory insufficiency
Authors:
- 1 January 1994
- journal article
- clinical trial
- Published by Springer Nature in Intensive Care Medicine
- Vol. 20 (1) , 42-44
Abstract
Evaluation of efficacy of intravenous flecainide to revert supraventricular arrhythmias to sinus rhythm in patients with respiratory insufficiency. Comparative randomized prospective trial. ICU in a University Hospital 30 patients with acute respiratory insufficiency or acute exscerbation of chronic respiratory insufficiency and supraventricular arrhythmias. Intravenous flecainide was administered to 15 patients (Group A) (2 mg/kg for 10 min and continuous perfusion of 1.5 mg/kg for 1 h). Intravenous verapamil was administered to 15 patients (Group B) (0.15 mg/kg for 5 min and continuous perfusion of 0.005 mg/kg/min for 1 h). The categories of patients' arrhythmias were: Group A — atrial fibrillation (AF) in 5 cases, atrial flutter (AFl) in 2, multifocal atrial tachycardia (MAT) in 4 and other supraventricular tachycardia (SVT) in 4. Group B — AF in 6 cases, AFL in 2, MAT in 2 and SVT in 5 cases. Flecainide reverted arrhythmias to sinus rhythm in 12 out of 15 cases (80%); of these 12, 11 reverted with the initial bolus. Verapamil reverted 5 out of 12 cases (33.3%,p<0.01). No significant secondary adverse effects were detected. Intravenous flecainide is an effective antiarrhythmic drug to treat acute supraventricular arrhythmias in patients with respiratory insufficiency.Keywords
This publication has 11 references indexed in Scilit:
- Mortality in patients treated with flecainide and encainide for supraventricular arrhythmiasThe American Journal of Cardiology, 1991
- Multifocal atrial tachycardia: Mechanisms, clinical correlates, and treatmentAmerican Heart Journal, 1989
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Role of the electrocardiogram in determining electrophysiologic end points of drug therapyThe American Journal of Cardiology, 1988
- A randomized, double-blind, placebo-controlled study of verapamil and metoprolol in treatment of multifocal atrial tachycardiaThe American Journal of Medicine, 1988
- Intravenous flecainide acetate for supraventricular tachycardiasThe American Journal of Cardiology, 1988
- Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillationThe American Journal of Cardiology, 1987
- FlecainideNew England Journal of Medicine, 1986
- Cardiac arrhythmias in hospitalized patients with chronic obstructive pulmonary disease.1973
- Arrhythmias Associated with Acute Respiratory Failure in Patients with Chronic Airway ObstructionChest, 1973